Top 10 Companies in the (R)-(-)-3-Chloro-1,2-propanediol (CAS 57090-45-6) Market (2026): Market Leaders Driving Global Chemical Supply

MARKET INSIGHTS

Global (R)-(-)-3-Chloro-1,2-propanediol (CAS 57090-45-6) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 6.4% during the forecast period.

(R)-(-)-3-Chloro-1,2-propanediol, commonly referred to as (R)-(-)-3-MCPD, is a chiral halogenated diol compound with significant utility as a chemical intermediate in asymmetric synthesis. Its well‑defined stereospecificity makes it an essential building block in the production of pharmaceuticals, agrochemicals, and specialty fine chemicals, where precise enantiomeric configuration is critical to end‑product efficacy and regulatory compliance.

(R)-(-)-3-Chloro-1,2-propanediol (CAS 57090-45-6) Market – View in Detailed Research Report

Top 10 Companies in the (R)-(-)-3-Chloro-1,2-propanediol (CAS 57090-45-6) Market (2026)

1. Tokyo Chemical Industry Co., Ltd. (Japan)

Headquarters: Tokyo, Japan
Key Offering: High‑purity chiral intermediates for pharmaceutical and fine‑chemical applications

Tokyo Chemical Industry has a long track record in asymmetric synthesis, providing reliable supply chains for beta‑blocker and antiviral intermediates. Its production facilities emphasize rigorous quality control, enabling rapid response to regulatory shifts in the pharma sector.

Sustainability & Growth Initiatives:

• Investing in continuous‑flow resolution to cut solvent usage by 30%
• Partnerships with academic institutions to develop greener biocatalytic routes
• Commitment to reducing carbon footprint through renewable energy procurement

2. Merck KGaA (Germany)

Headquarters: Darmstadt, Germany
Key Offering: Advanced chiral synthesis platforms and cGMP‑grade intermediates

Merck’s expertise in enzymatic resolution and process scale‑up supports high‑value API production. The company’s global distribution network ensures consistent supply to key pharma markets.

Sustainability & Growth Initiatives:

• Biocatalysis research to replace hazardous reagents
• Targeted waste‑reduction programs achieving 25% lower effluent volumes
• Digitalization of production for real‑time quality assurance

3. BASF SE (Germany)

Headquarters: Ludwigshafen, Germany
Key Offering: Fine‑chemical intermediates for agrochemical and specialty‑chemical sectors

BASF leverages its global R&D footprint to deliver chiral building blocks with high enantiomeric excess, supporting the growing demand for stereoselective pesticides and herbicides.

Sustainability & Growth Initiatives:

• Investment in renewable feedstock sourcing for raw materials
• Implementation of circular‑chemistry principles across production lines
• Partnerships with downstream manufacturers to co‑develop eco‑friendly formulations

4. Lonza Group Ltd. (Switzerland)

Headquarters: Basel, Switzerland
Key Offering: Custom synthesis services for high‑purity chiral intermediates

Lonza’s contract‑manufacturing arm provides tailored solutions for pharma and biotech firms, ensuring compliance with cGMP and regulatory requirements.

Sustainability & Growth Initiatives:

• Adoption of green chemistry guidelines in all contract processes
• Reduction of water consumption through closed‑loop systems
• Support for clients in achieving ESG targets via shared sustainability data

5. dsm‑firmenich (Switzerland)

Headquarters: Binningen, Switzerland
Key Offering: High‑purity chiral intermediates for pharmaceutical and specialty‑chemical markets

dsm‑firmenich’s expertise in chiral resolution and scalable synthesis enables it to meet the stringent purity demands of the pharma sector.

Sustainability & Growth Initiatives:

• Investment in enzymatic processes to reduce hazardous waste
• Targeted energy‑efficiency upgrades across production facilities
• Collaboration with downstream partners to optimize end‑product sustainability

6. Hairui Fine Chemicals Co., Ltd. (China)

Headquarters: Shanghai, China
Key Offering: Cost‑effective chiral intermediates for domestic and export markets

Hairui has expanded its capacity with new plants featuring advanced resolution technologies, positioning it as a key supplier in the rapidly growing Asia‑Pacific market.

Sustainability & Growth Initiatives:

• Implementation of continuous‑flow processes to lower energy consumption
• Use of renewable electricity in manufacturing sites
• Engagement with local governments to support green‑chemistry incentives

7. Capot Chemical Co., Ltd. (China)

Headquarters: Guangzhou, China
Key Offering: High‑purity chiral intermediates for pharmaceutical and fine‑chemical sectors

Capot’s focus on process optimization and quality assurance has enabled it to capture a growing share of the domestic pharma market.

Sustainability & Growth Initiatives:

• Adoption of green‑chemistry protocols in all production stages
• Reduction of solvent usage through catalytic process redesign
• Participation in industry forums to share best practices for sustainability

8. Biosynth (Switzerland)

Headquarters: Zürich, Switzerland
Key Offering: Research‑grade chiral intermediates for academic and industrial use

Biosynth focuses on providing high‑purity reagents for research institutions and small‑to‑medium enterprises, ensuring strict compliance with analytical standards.

Sustainability & Growth Initiatives:

• Use of biodegradable solvents in laboratory processes
• Development of scalable biocatalytic pathways
• Active engagement with academic partners on green‑chemistry projects

9. Apollo Scientific Ltd. (UK)

Headquarters: Manchester, United Kingdom
Key Offering: Custom synthesis for pharma and fine‑chemical markets

Apollo Scientific offers tailored production solutions, emphasizing quality and compliance with regulatory standards for both domestic and international clients.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient equipment across facilities
• Partnerships with suppliers to source low‑toxicity reagents
• Support for clients in meeting carbon‑neutral production targets

10. Alfa Aesar (USA)

Headquarters: West Lafayette, Indiana, USA
Key Offering: High‑purity chiral intermediates for pharmaceutical and research applications

Alfa Aesar’s extensive product portfolio and robust distribution network provide reliable supply of (R)-(-)-3‑MCPD for advanced research and industrial use.

Sustainability & Growth Initiatives:

• Adoption of green‑chemistry guidelines in all production lines
• Continuous improvement of waste‑management processes
• Collaboration with customers to develop sustainable product solutions

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/307459/chloropropanediol-market

Get Full Report Here: https://www.24chemicalresearch.com/reports/307459/chloropropanediol-market

Market Outlook to 2034

The trajectory of the (R)-(-)-3‑Chloro‑1,2‑propanediol market is driven by sustained demand for enantiopure intermediates in pharmaceutical development, particularly for single‑enantiomer APIs. Coupled with the expansion of fine‑chemical manufacturing in Asia‑Pacific and the adoption of continuous‑flow synthesis, the market is expected to maintain a steady growth rate, with key players investing in process efficiencies to manage cost pressures.

Emerging Trends and Opportunities

• Continued shift toward biocatalytic resolution, reducing solvent use and energy consumption.
• Expansion of chiral intermediates into agrochemical applications, driven by demand for stereoselective pesticides.
• Growth of custom synthesis services to meet the specific needs of biopharmaceutical companies.
• Increased focus on sustainability metrics, with companies reporting lower carbon footprints and higher waste‑recycling rates.
• Development of integrated digital platforms for real‑time quality monitoring and supply‑chain transparency.